Dallas, Texas (PRWEB) February 15, 2014
The global high content screening market is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery.
The high content screening software market is the fastest-growing segment in the high content screening market. In high content screening, the accuracy of the results obtained depends on image analysis and data management software. In recent years, enhanced image analysis and data management solutions have been introduced, but there is scope for these solutions to be further improvised to provide improved results. Many of the key players in the high content screening instruments market are collaborating with software companies to offer products with better software. For instance, in November 2010, PerkinElmer collaborated with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging software solution for microscopy. With the data sharing facility, Columbus Scope helps in data management in high content screening.
Complete report available at http://www.rnrmarketresearch.com/high-content-screening-market-by-instruments-cell-imaging-and-analysis-system-by-applications-primary-and-secondary-screening-target-identification-and-validation-toxicity-studies-compound-prof-market-report.html.
In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for high content screening. This region offers a high growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, Global Health Innovative Technology Fund (GHIT Fund), granted $5.7 million to six global partnerships to support the R&D activities of these partnerships in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such fundings are expected to boost the growth of the high content screening market.
The global high content screening market is competitive and all the existing players in this market are engaged in developing new and advanced products to maintain their market shares.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
The report provides insights on the following pointers:
Order a Purchase Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=148396.
Browse more reports on Drug Discovery Market at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/drug-discovery.
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.